ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Dalfampridine in Parkinson's disease related gait dysfunction: A randomized double blind trial
Journal of the Neurological Sciences
◽
10.1016/j.jns.2017.05.011
◽
2017
◽
Vol 379
◽
pp. 7-11
◽
Cited By ~ 2
Author(s):
Corneliu C. Luca
◽
Gloria Nadayil
◽
Chuanhui Dong
◽
Fatta B. Nahab
◽
Edelle Field-Fote
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Double Blind Trial
◽
Double Blind
◽
Blind Trial
◽
Gait Dysfunction
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717995409.793474520
◽
2013
◽
Author(s):
Cynthia Comella
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Extended Release
◽
Immediate Release
◽
Motor Fluctuations
◽
Double Blind Trial
◽
Phase 3
◽
Double Blind
◽
Blind Trial
Download Full-text
The Parkinson-Control study: A 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease
Movement Disorders
◽
10.1002/mds.20750
◽
2005
◽
Vol 21
(4)
◽
pp. 500-509
◽
Cited By ~ 29
Author(s):
Alexandre Castro-Caldas
◽
Paul Delwaide
◽
Wolfgang Jost
◽
Marcelo Merello
◽
Adrian Williams
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Double Blind Trial
◽
Double Blind
◽
Blind Trial
◽
Control Study
Download Full-text
Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
The Lancet Neurology
◽
10.1016/s1474-4422(13)70025-5
◽
2013
◽
Vol 12
(4)
◽
pp. 346-356
◽
Cited By ~ 120
Author(s):
Robert A Hauser
◽
Ann Hsu
◽
Sherron Kell
◽
Alberto J Espay
◽
Kapil Sethi
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Extended Release
◽
Immediate Release
◽
Motor Fluctuations
◽
Double Blind Trial
◽
Phase 3
◽
Double Blind
◽
Blind Trial
Download Full-text
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
Journal of Psychopharmacology
◽
10.1177/0269881114550355
◽
2014
◽
Vol 28
(11)
◽
pp. 1088-1098
◽
Cited By ~ 113
Author(s):
Marcos Hortes N Chagas
◽
Antonio W Zuardi
◽
Vitor Tumas
◽
Márcio Alexandre Pena-Pereira
◽
Emmanuelle T Sobreira
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Double Blind Trial
◽
Double Blind
◽
Blind Trial
Download Full-text
Faculty Opinions recommendation of Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717995409.793473992
◽
2013
◽
Author(s):
Werner Poewe
◽
Philipp Mahlknecht
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Extended Release
◽
Immediate Release
◽
Motor Fluctuations
◽
Double Blind Trial
◽
Phase 3
◽
Double Blind
◽
Blind Trial
Download Full-text
Double-blind trial of pergolide for Parkinson's disease
Neurology
◽
10.1212/wnl.35.3.291
◽
1985
◽
Vol 35
(3)
◽
pp. 291-291
◽
Cited By ~ 42
Author(s):
S. G. Diamond
◽
C. H. Markham
◽
L. J. Treciokas
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Double Blind Trial
◽
Double Blind
◽
Blind Trial
Download Full-text
Adjuvant treatment of Parkinson's disease with budipine: a double-blind trial versus placebo
Journal of Neurology
◽
10.1007/bf00314280
◽
1987
◽
Vol 234
(5)
◽
pp. 280-282
◽
Cited By ~ 24
Author(s):
Kurt Jellinger
◽
Harald Bliesath
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Adjuvant Treatment
◽
Double Blind Trial
◽
Double Blind
◽
Blind Trial
Download Full-text
Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double-blind trial
Movement Disorders
◽
10.1002/mds.23929
◽
2011
◽
Vol 27
(2)
◽
pp. 219-226
◽
Cited By ~ 46
Author(s):
Robert Chinnapongse
◽
Kristen Gullo
◽
Paul Nemeth
◽
Yuxin Zhang
◽
Lynn Griggs
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Botulinum Toxin
◽
Botulinum Toxin Type
◽
Double Blind Trial
◽
Type B
◽
Double Blind
◽
Safety And Efficacy
◽
Blind Trial
◽
Botulinum Toxin Type B
Download Full-text
Selegiline (L-Deprenyl) and L-Dopa Treatment of Parkinson's Disease: A Double-Blind Trial.
Internal Medicine
◽
10.2169/internalmedicine.33.517
◽
1994
◽
Vol 33
(9)
◽
pp. 517-524
◽
Cited By ~ 13
Author(s):
Mitsuo TAKAHASHI
◽
Ryoichi YUASA
◽
Terukuni IMAI
◽
Hisao TACHIBANA
◽
Shiro YORIFUJI
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Double Blind Trial
◽
Double Blind
◽
Blind Trial
Download Full-text
Faculty Opinions recommendation of Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717995409.793475706
◽
2013
◽
Author(s):
Olivier Rascol
◽
Santiago Perez-Lloret
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Extended Release
◽
Immediate Release
◽
Motor Fluctuations
◽
Double Blind Trial
◽
Phase 3
◽
Double Blind
◽
Blind Trial
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close